Adrenocortical corticotropic insufficiency secondary to the use of cosmetic dermocorticoids
Abstract
Keywords
Full Text:
PDFReferences
Dadzie OE, Petit A. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents. JEADV 2009; 23(7):741-750.
Faye O, Keita S, Diakité FS, Konaré HD, Ndiaye HT. Side effects of de-pigmenting products in Bamako, Mali. Int J Dermatol 2005; 44(Suppl. 1):35-36.
Ajose FOA. Consequences of skin bleaching in Nigerian men and women. Int J Dermatol 2005; 44(Suppl. 1):41-43.
Traoré A, Kadéba JC, Niamba P, Barro F, Ouedraogo L.. Use of cutaneous depigmenting products by women in two towns in Burkina Faso: epidemiologic data, motivations, products and sides effects. Int J Dermatol 2005; 44(Suppl. 1):30-32.
Adebajo SB. An epidemiological survey of the use of cosmetic skin lightening cosmetics among traders in Lagos, Nigeria. West Afr J Med 2002; 21(1):51-55.
Pitché P, Kombaté K, Tchangai-Walla K. Cosmetic use of skin-bleaching products and associated complications. Int J Dermatol 2005; 44(Suppl. 1):39-40.
Sène D, Huong-Boutin DLT, Thiollet M, Barete S, Cacoub P, Piette JC. Insuffisance surrénalienne haute symptomatique compliquant l’usage de dermocorticoïdes pour dépigmentation volontaire. Rev Méd Interne 2008; 29(12):1030-1033.
Kouotou EA, Bissek AZ, Nouind CC, Defo D, Sieleunou I, Ndam EC. Dépigmentation volontaire: pratiques et dermatoses associées chez les commerçantes de Yaoundé (Cameroun). Ann Dermatol Venerol 2015; 142(6-7):443-445.
Lewin C, Malbach HI. Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am J Clin Dermatol 2002; 3(3):141-147.
Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds: Medical and psychosocial aspects. Dermatol Clin 2011; 29(1):111-123.
Boëkle B, Jara D, Nindi W, Aberer W, Sepp NT. Adrenal insufficiency as a result of long-term misuse of topical corticosteroids. Dermatology 2014; 228(4):289-293.
Boyle J, Kennedy CT. Hydroquinone concentrations in skin lightening creams.Br J Dermatol 1986; 114(4):501-504.
Perret JL, Sane M, Gning S, Ba K, Rohou G. Hypothalamo-hypophyseal-adrenal hypo-function caused by the use of bleaching cosmetics in Senegal. Bull Soc Pathol Exot 2001; 94:249-252.
Sobngwi E, Lubin V, Ury P, et al. Insuffisance corticotrope et diabète sucré secondaire à l’usage des dermocorticoïdes à visée cosmétiques. Ann Endocrinol 2003; 64:203-204.
Raynaud E, Cellier C, Perret JL. Dépigmentation cutanée à visée cosmétique: Enquête de prévalence et effets indésirables dans une population féminine sénégalaise. Ann Dermatol Venerol 2001; 128(6-7):720-724.
DOI: http://dx.doi.org/10.22551/2019.25.0604.10158
Copyright (c) 2020 Annelie Kérékou Hodé, Hubert Dédjan
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975